MEP2908A - Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation - Google Patents

Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation

Info

Publication number
MEP2908A
MEP2908A MEP-29/08A MEP2908A MEP2908A ME P2908 A MEP2908 A ME P2908A ME P2908 A MEP2908 A ME P2908A ME P2908 A MEP2908 A ME P2908A
Authority
ME
Montenegro
Prior art keywords
preparation
polymorphic forms
novel crystalline
lercanidipine hydrochloride
crystalline polymorphic
Prior art date
Application number
MEP-29/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Fausto Bonifacio
Francesco Campana
Iasi Gianluca De
Amedeo Leonardi
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11448245&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP2908(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of MEP2908A publication Critical patent/MEP2908A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
MEP-29/08A 2001-08-06 2002-08-05 Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation MEP2908A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001726A ITMI20011726A1 (it) 2001-08-06 2001-08-06 Forme polimorfe della lercanidipina cloridrato
PCT/EP2002/008699 WO2003014084A1 (en) 2001-08-06 2002-08-05 Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation

Publications (1)

Publication Number Publication Date
MEP2908A true MEP2908A (en) 2010-10-10

Family

ID=11448245

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-29/08A MEP2908A (en) 2001-08-06 2002-08-05 Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
MEP-2008-29A ME01525B (me) 2001-08-06 2002-08-05 Novi kristalni polimorfni oblici lerkanidipin hidrohlorida i postupak za njihovo dobijanje

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2008-29A ME01525B (me) 2001-08-06 2002-08-05 Novi kristalni polimorfni oblici lerkanidipin hidrohlorida i postupak za njihovo dobijanje

Country Status (36)

Country Link
EP (4) EP1600441B1 (ru)
JP (1) JP2005504045A (ru)
KR (3) KR20050043992A (ru)
CN (2) CN100448847C (ru)
AP (1) AP1766A (ru)
AR (1) AR037139A1 (ru)
AT (2) ATE453624T1 (ru)
AU (1) AU2002327924C1 (ru)
BR (1) BR0211739A (ru)
CY (2) CY1109711T1 (ru)
DE (2) DE60206787T2 (ru)
DK (3) DK1600441T3 (ru)
EA (1) EA005673B1 (ru)
EC (1) ECSP044973A (ru)
ES (3) ES2334678T3 (ru)
HK (3) HK1067123A1 (ru)
HR (1) HRP20040156B1 (ru)
HU (1) HU229563B1 (ru)
IL (3) IL164648A0 (ru)
IT (1) ITMI20011726A1 (ru)
MA (1) MA27133A1 (ru)
ME (2) MEP2908A (ru)
MX (1) MXPA04001069A (ru)
NO (2) NO325541B1 (ru)
NZ (2) NZ541341A (ru)
OA (1) OA12648A (ru)
PE (1) PE20030328A1 (ru)
PL (1) PL216066B1 (ru)
PT (2) PT2157083E (ru)
RS (1) RS52161B (ru)
SI (3) SI1600441T1 (ru)
TN (1) TNSN04024A1 (ru)
UA (1) UA82988C2 (ru)
UY (1) UY27410A1 (ru)
WO (1) WO2003014084A1 (ru)
ZA (1) ZA200401806B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011726A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
AR043395A1 (es) * 2003-02-28 2005-07-27 Recordati Ireland Ltd Terapia de combinacion para la hipertension utilizando lercanidipina y un bloqueante de los receptores de angiotensina ii
DE04801160T1 (de) * 2003-12-01 2007-08-09 Lifecycle Pharma A/S Pharmazeutische zusammensetzungen mit lercanidipin
AR052918A1 (es) 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
US8097729B2 (en) 2005-09-16 2012-01-17 Glenmark Generics Ltd. Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
KR100821165B1 (ko) * 2006-03-10 2008-04-14 동우신테크 주식회사 레르카니디핀 염산염의 제조 방법
EP2114883A4 (en) * 2006-12-29 2010-09-08 Dongwoo Syntech Co Ltd PROCESS FOR THE PREPARATION OF LERCANIDIPINE HYDROCHLORIDE
EP2121575A2 (en) * 2007-03-05 2009-11-25 Actavis Group PTC EHF Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate
EP2585051B2 (en) 2010-06-23 2020-04-08 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
EP2444394A1 (en) 2010-10-21 2012-04-25 Alembic Pharmaceuticals Limited Process for the preparation of amorphous form of lercanidipine HCI
EP2654729B1 (en) 2010-12-24 2016-05-04 KRKA, d.d., Novo mesto Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
JP2014511867A (ja) * 2011-04-18 2014-05-19 合肥貝霓医薬科技有限公司 ジヒドロピリジン系カルシウムチャネルブロッカーの精製、及びそのナノ粒子の調製方法
CN102558032B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 一种无定形盐酸乐卡地平及其制备方法
CN102531999B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 无定形盐酸乐卡地平及其制备方法
CN102584682A (zh) * 2011-12-31 2012-07-18 苏州二叶制药有限公司 盐酸乐卡地平的制备方法
CN103497075B (zh) * 2013-09-25 2016-03-23 山西北化关铝化工有限公司 水悬浮延期药造型粉
CN109232389B (zh) * 2018-05-15 2021-10-08 迪嘉药业集团有限公司 一种小粒度硝苯地平的结晶制备方法
CN115353485B (zh) * 2022-07-26 2024-04-19 山西双雁药业有限公司 从硝苯地平母液中回收硝苯地平的方法及应用
CN115671066B (zh) * 2022-11-21 2024-07-02 安徽宏业药业有限公司 一种盐酸乐卡地平片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US596139A (en) * 1897-12-28 Process of generating acetylene gas
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
IT1274480B (it) * 1995-05-12 1997-07-17 Recordati Chem Pharm Procedimento migliorato per la preparazione della lercanidipina cloridrato
US5696139A (en) * 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
US5912351A (en) * 1995-05-12 1999-06-15 Recordati, S.A. Chemical And Pharmaceutical Company Anhydrous 1,4-Dihydropyridines and salts thereof
IT1275532B (it) * 1995-07-14 1997-08-07 Recordati Chem Pharm Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
KR20030031886A (ko) 2000-02-16 2003-04-23 뉴로젠 코포레이션 치환된 아릴피라진
ITMI20011726A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US20040198789A1 (en) 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations

Also Published As

Publication number Publication date
ITMI20011726A1 (it) 2003-02-06
RS52161B (en) 2012-08-31
NO20040266L (no) 2004-03-24
EP2157083A2 (en) 2010-02-24
IL164648A0 (en) 2005-12-18
RS11304A (en) 2007-02-05
KR20040030903A (ko) 2004-04-09
DE60206787D1 (de) 2006-03-02
KR100626819B1 (ko) 2006-09-20
DK1432683T3 (da) 2006-03-06
ZA200401806B (en) 2005-06-29
BR0211739A (pt) 2004-09-28
HK1067123A1 (en) 2005-04-01
EP1432683A1 (en) 2004-06-30
CY1117051T1 (el) 2017-04-05
AR037139A1 (es) 2004-10-27
SI1432683T1 (sl) 2006-04-30
ES2334678T3 (es) 2010-03-15
HUP0401163A2 (hu) 2004-09-28
AP2004002989A0 (en) 2004-03-31
TNSN04024A1 (en) 2006-06-01
HU229563B1 (en) 2014-02-28
HK1140487A1 (en) 2010-10-15
DK1600441T3 (da) 2010-02-08
EP1600441A2 (en) 2005-11-30
DE60206787T2 (de) 2006-07-13
NO325541B1 (no) 2008-06-16
IL153917A0 (en) 2003-07-31
HUP0401163A3 (en) 2009-04-28
ES2212759T3 (es) 2006-04-16
ECSP044973A (es) 2004-06-28
SI2157083T1 (sl) 2016-01-29
CY1109711T1 (el) 2014-08-13
CN101475524B (zh) 2012-08-29
MXPA04001069A (es) 2005-02-17
ES2212759T1 (es) 2004-08-01
EP1600441B1 (en) 2009-12-30
EA005673B1 (ru) 2005-04-28
IL164648A (en) 2007-02-11
EP1432683B1 (en) 2005-10-19
UA82988C2 (ru) 2008-06-10
PL216066B1 (pl) 2014-02-28
DE60234961D1 (de) 2010-02-11
NO335651B1 (no) 2015-01-19
PT2157083E (pt) 2016-01-22
KR20050111799A (ko) 2005-11-28
EP1600441A3 (en) 2005-12-07
NZ531558A (en) 2005-12-23
IL153917A (en) 2005-11-20
NO20082330L (no) 2004-03-24
PT1600441E (pt) 2010-01-20
NZ541341A (en) 2007-02-23
EP2036890A1 (en) 2009-03-18
CN101475524A (zh) 2009-07-08
OA12648A (en) 2006-06-16
UY27410A1 (es) 2003-03-31
JP2005504045A (ja) 2005-02-10
ITMI20011726A0 (it) 2001-08-06
ATE307114T1 (de) 2005-11-15
EP2157083A3 (en) 2010-03-24
HK1086263A1 (en) 2006-09-15
AU2002327924B2 (en) 2008-04-24
ME01525B (me) 2011-02-10
KR20050043992A (ko) 2005-05-11
EA200400280A1 (ru) 2004-08-26
KR100667687B1 (ko) 2007-01-12
PL369522A1 (en) 2005-05-02
DK2157083T3 (en) 2015-11-02
CN1538957A (zh) 2004-10-20
SI1600441T1 (sl) 2010-02-26
EP1432683B9 (en) 2006-01-18
AP1766A (en) 2007-08-10
ES2555213T3 (es) 2015-12-29
EP2157083B1 (en) 2015-09-30
HRP20040156A2 (en) 2004-08-31
HRP20040156B1 (en) 2012-03-31
PE20030328A1 (es) 2003-05-09
AU2002327924C1 (en) 2009-12-10
ATE453624T1 (de) 2010-01-15
MA27133A1 (fr) 2005-01-03
WO2003014084A1 (en) 2003-02-20
CN100448847C (zh) 2009-01-07

Similar Documents

Publication Publication Date Title
MEP2908A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
HUP0001539A2 (hu) 2-(1-Imino-etil-amino)-etil-homocisztein, eljárás előállítására és az ezt tartalmazó gyógyszerkészítmények
HUP0302793A3 (en) N-substituted aniline derivatives useful as phosphodiesterase 4 inhibitors, pharmaceutical compositions containing them and process for their preparations
AP1830A (en) Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same.
HUP0204010A2 (hu) Új szertralin-hidroklorid polimorfok, eljárás az előállításukra, az új polimorfokat tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0203559A3 (en) Polymorphic forms of sertraline hydrochloride, process for their preparation and pharmaceutical compositions containing them
NO20061575L (no) Fremgangsmate for fremstilling av renzapride og mellomprodukter derav
NO20020282L (no) Nytt difenyl-piperidinderivat
NO20023643L (no) Forbindelser som har antitumoraktivitet, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholderdem
DK0579681T3 (da) Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse
PA8527401A1 (es) 7-oxo-piridopirimidinas (ii)
ATE276262T1 (de) Oxazinochinolone für die behandlung viraler infektionen
HUP0204318A2 (en) Torsemide polymorphic forms, process for their preparation, pharmaceutical compositions containing them and their use
NO20025015D0 (no) Et pyridin-1-oksidderivat, og fremgangsmåte for dets overföring til farmasöytisk effektive forbindelser
HUP0300972A2 (hu) Gatifloxacin-pentahidrát
NO20031643D0 (no) Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
HUP0401161A2 (hu) Lerkanidipin-hidroklorid szolvátjai és lerkanidipin-hidroklorid új kristályos formái, eljárás előállításukra és a kristályos formákat tartalmazó gyógyászati készítmények
NO20034985D0 (no) Nye 5-tio-SS-D-xylopyranosid-derivater, fremgangsmåte for fremstilling derav, farmasöytiske blandinger inneholdende dem og den terapeutiskeanvendelse derav
BR0210099A (pt) Agentes antibacterianos
SI1146044T1 (en) CNS active cyclobuta-indole carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them
WO2003039457A3 (en) Anti-mycobacterial compounds
DK1270562T3 (da) Cykliske alfa-amino-gamma-hydroxyamider, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger heraf
EP1774965A3 (en) Novel sertraline hydrochloride polymorph, processes for preparing them, compositions containing them and methods of using them
TH68163A (th) อิมิดาโซควิโนลีนซึ่งถูกแทนที่ด้วยอะมิโดอีเทอร์
DK1157028T3 (da) Nye 11.beta-substituerede steroidderivater, fremgangsmåde til deres fremstilling og mellemprodukter deraf, deres anvendelse som lægemidler og farmaceutiske præparater med indhold heraf